DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe02050 SLP10 L-Glu- L-Val- D-Leu- L-Asp- D-Leu PEDV 30973929
DRAVPe02061 SP-10-1  CDIPIGAGICAS SARS-CoV 16337697
DRAVPe02062 SP-10-2 YHTVSLLRSTSQ SARS-CoV 16337697
DRAVPe02063 SP-10-3  SLLRSTSQKSIV SARS-CoV 16337697
DRAVPe02064 SP-10-4  KSIVAYTMSLGA SARS-CoV 16337697
DRAVPe02065 SP-10-5 AYTMSLGADSSI SARS-CoV 16337697
DRAVPe02071 Brevicillin SDSVVSDIICTTFCSVTWCQSNCC SARS-CoV-2 36914211
DRAVPe02089 S4 FNCYFPLQSYGFQPTNGVGYK SARS-CoV-2 38917689
DRAVPe02090 S2 YNYLYRLFC SARS-CoV-2 38917689
DRAVPe02091 S5 LNCYWPLNDYGFYTTTGIGYK SARS-CoV-2 38917689
DRAVPe02093 4H30 GAICHPVFCPRRYKQIGTCGLPGTKCCKKP SARS-CoV-2 35768416
DRAVPe02094 Melittin of bee venom GIGAVLKYLTTGLPALISWIKRKROQ SARS-CoV-2 35236909
DRAVPe02132 HKU4-HR2P2 EISKINTTLLDLSDEMAMLQQEVVKQLNDSYIDLKEL MERS-CoV , SARS-CoV. 30646495
DRAVPe02134 HKU4-HR2P1 GENFAISKINTTLLDISDEMAMIQEVVKQLNDSYI MERS-CoV 30646495
DRAVPe02147 MERS-HR2P SITQINTTLLDTTYEMISIQQVVKALNESYIDLKEL MERS-CoV 33082259
DRAVPe02148 SARS-CoV-2 HRC DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGCTEG SARS-CoV-2 and MERS-CoV 20032190
DRAVPe02149 HKU4-HR2P3  LDLSDEMAMIEVVKQLNDSYIDLKELSNYTYYNKW MERS-CoV 30646495
DRAVPe02150 NP-1 GVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQ SARS-CoV 15043961
DRAVPe02151 N/A SGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL SARS-CoV-2 14499001
DRAVPe02152 P2 PTTFMLKYDENGTITDAVDC SARS-CoV-2 15918330
DRAVPe02153 P6 YQDVNCTDVSTAIHADQLTP SARS-CoV-2 15918330
DRAVPe02154 SP-10 (residues 668-679) STSQKSIVAYTM SARS-CoV 16337697
DRAVPe02155 P5 +14 GGGYSKAQKAQAKQAKQAQKAQKAQAKQAKQAQKAQKAQAKQAKQ SARS-CoV 32913137
DRAVPe02156 P8 QYGSFCTQLNRALSGIAAEQ SARS-CoV 15918330
DRAVPe02157 P10 IQKEIDRLNEVAKNLNESLI SARS-CoV 15918330
DRAVPe02158 MERS-5HB GGRGGGGSGGSGGSGGRGGGGSGGSGG MERS-CoV 28906430
DRAVPe02159 229E-HR2P VVEQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWL SARS-CoV 29415501
DRAVPe02160 Octapeptide AVLQSGFR SARS-CoV 16242214
DRAVPe02161 6a LQQFMK SARS-CoV 16451084
DRAVPe02162 Protected tetrapeptide AVLQ SARS-CoV 25224114
First 4 5 6 7 8 9 10 Last